Retroviral intasome assembly and inhibition of DNA strand transfer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within the CIC, the IN dimers are bridged via the exchange of associated NTDs and are joined by a pair of CTDs (referred to as the synaptic CTDs), which act as rigid spacers.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the intasomes from the prototype foamy virus (PFV, a simiispumavirus) as well as the δ-retroviruses HTLV-1 and simian T-cell lymphotropic virus (STLV) contain four IN subunits (arranged as a dimer-of-dimers)25,29,37,38”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
Gouet, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg556 · Cited by 1,509
Research works printed but not linked: 2
- Grobler, J. A., Stillmock, K., Miller, M. D. & Hazuda, D. J. Mechanism by which the HIV integrase active-site mutation N155H confers resistance to raltegravir. Antivir. Ther. 13 (suppl. 3). A41 (2008)
- Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EAMCB Newsletter on Protein Crystallography no. 26, (1992)
Cited by
Items 301–400 of 719
Yoshinaga, T., Seki, T., Miki, S., Miyamoto, T., Suyama, A., Kawauchi, S., Kobayashi, M., Sato, A., Stewart, E. L., Underwood, M., et al. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.01.013 · Cited by 21
Eurtivong, C., Choowongkomon, K., Ploypradith, P., & Ruchirawat, S. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02811 · Cited by 21
“The π π stacking interactions is predicted to contribute to the stability of the inhibitor-protein/DNA complex, which is seen in X-ray structures of approved drugs with viral intasome complexes [38, 39].”
BackgroundRetroviral Integrases Promote Fraying of Viral DNA Ends
Katz, R. A., Merkel, G. W., Andrake, M., Röder, H., & Skalka, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229179 · Cited by 19
Hajimahdi, Z., Zabihollahi, R., Aghasadeghi, M. R., & Zarghi, A. (2013) · Drug Research · doi:10.1055/s-0033-1334964 · Cited by 20
HIV-1 exploits the Fanconi anemia pathway for viral DNA integration
Fu, S., Phan, A. T., Mao, D., Wang, X., Gao, G., Goff, S. P., & Zhu, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110840 · Cited by 24
“…- processing, HIV-1 IN binds both ends of viral DNA and removes a dinucleotide (5 ′ -GT-3 ′ ) at the 3 ′ end of each viral LTR DNA via hydrolysis of a phosphodiester bond, which liberates the 3 ′ -hydroxyl groups of highly conserved 5 ′ -CA-3 ′ dinucleotides (Chen et al., 1999; Hare et al., 2010).”
New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?
Ndashimye, E., Reyes, P. S., & Arts, E. J. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac040 · Cited by 25
Zhou, B., Yang, K., Wills, E. G., Tang, L., & Baines, J. D. (2014) · Journal of Virology · doi:10.1128/jvi.01540-14 · Cited by 21
Uneven Genetic Robustness of HIV-1 Integrase
Rihn, S. J., Hughes, J., Wilson, S. J., & Bieniasz, P. D. (2014) · Journal of Virology · doi:10.1128/jvi.02451-14 · Cited by 26
“Determination of the crystal structure of the prototype foamy virus (PFV) intasome illuminated how IN domains contribute to protein multimerization, as well as to vDNA and host DNA binding (26, 27).”
BackgroundRetroviral integrase protein and intasome nucleoprotein complex structures
Grawenhoff, J., & Engelman, A. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.32 · Cited by 26
Self-citationPathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance
Malet, I., Ambrosio, F. A., Subra, F., Herrmann, B., Leh, H., Bouger, M.-C., Artese, A., Katlama, C., Talarico, C., Romeo, I., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx529 · Cited by 21
Multivalent interactions essential for lentiviral integrase function
Ballandras-Colas, A., Chivukula, V., Gruszka, D. T., Shan, Z., Singh, P. K., Pye, V. E., McLean, R. K., Bedwell, G. J., Li, W., Nans, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29928-8 · Cited by 25
“The resulting reconstruction showed features suggesting presence of IBD bound to two symmetric positions within the CIC.”
BackgroundMethodInfluentialSelf-citationHIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis
Zhang, Y., Lin, F., Li, K., Zhu, W., Liu, Y.-L., Cao, R., Pang, R., Lee, E., Axelson, J. C., Hensler, M. E., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300038t · Cited by 21
Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses
Le, G. T., Vandegraaff, N., Rhodes, D. I., Jones, E. D., Coates, J. A. V., Lü, L., Li, X., Yu, C., Feng, X., & Deadman, J. J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.041 · Cited by 20
Computer Tools in the Discovery of HIV-1 Integrase Inhibitors
Liao, C., & Nicklaus, M. C. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.193 · Cited by 21
The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function
Singer, M. R., Dinh, T., Levintov, L., Annamalai, A. S., Rey, J. S., Briganti, L., Cook, N., Pye, V. E., Taylor, I. A., Kim, K., et al. (2023) · mBio · doi:10.1128/mbio.03560-22 · Cited by 21
“that bind in the IN active site and arrest HIV-1 replication (2, 3).”
BackgroundSelf-citationPyridopyrimidinone inhibitors of HIV-1 RNase H
Velthuisen, E. J., Johns, B. A., Gerondelis, P., Chen, Y., Li, M., Mou, K., Zhang, W., Seal, J. W., Hightower, K. E., Miranda, S. R., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.061 · Cited by 20
Huhn, G. D., Badri, S. M., Vibhakar, S., Tverdek, F. P., Crank, C. W., Lubelchek, R., Max, B. E., Simon, D., Sha, B. E., Adeyemi, O. M., et al. (2010) · AIDS Research and Therapy · doi:10.1186/1742-6405-7-44 · Cited by 18
“HIV-1 integrase inhibitors specifically inhibit the viral enzyme integrase that catalyzes strand transfer insertion of proviral DNA into the host-cell genome [44, 45 ].”
BackgroundFun, A., Leitner, T., Vandekerckhove, L., Däumer, M., Thielen, A., Buchholz, B. M., Hoepelman, A. I. M., Gisolf, E. H., Schipper, P. J., Wensing, A. M. J., et al. (2018) · Retrovirology · doi:10.1186/s12977-017-0384-z · Cited by 20
“For instance, raltegravir resistance mutations Q148H/ K/R and N155H show a high level of cross-resistance with elvitegravir, but elvitegravir susceptibility is unaffected by Y143 mutations [30, 31], a difference that is beautifully explained by crystal structures of the intasome in presence of raltegravir or elvitegra…”
Nucleoprotein Intermediates in HIV-1 DNA Integration: Structure and Function of HIV-1 Intasomes
Craigie, R. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-10-8456-0_9 · Cited by 21
“Structure of prototype foamy virus (PFV) intasomes A major breakthrough in structural studies of intasomes came when the Cherepanov group solved the crystal structures of the prototype foamy virus (PFV) SSC and STC intasomes (Hare et al. 2010a; Maertens et al. 2010).”
BackgroundInfluentialMauro, E., Lesbats, P., Lapaillerie, D., Chaignepain, S., Maillot, B., Oladosu, O., Robert, X., Fiorini, F., Kieffer, B., Bouaziz, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz091 · Cited by 21
“Lentiviral MVV intasomes were tested in concerted integration assay since their assembly was previously fully described (18,19).”
MethodSmith, S. J., Zhao, X. Z., Passos, D. O., Pye, V. E., Cherepanov, P., Lyumkis, D., Burke, T. R., & Hughes, S. H. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00819 · Cited by 22
Self-citationEvaluation of the impact of multivalent metal ions on the permeation behavior of Dolutegravir sodium
Grießinger, J. A., Hauptstein, S., Laffleur, F., Netsomboon, K., & Bernkop‐Schnürch, A. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1115869 · Cited by 22
Biochemical Characterization of Novel Retroviral Integrase Proteins
Ballandras-Colas, A., Naraharisetty, H., Li, X., Serrao, E., & Engelman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076638 · Cited by 18
“Based on observations that PFV IN is primarily monomeric in solution [4,7] and that HIV-1 IN monomers can catalyze proficient concerted integration activity in the absence of LEDGF/p75 protein [32], there is some reason to believe that monomers serve as obligate intermediates in intasome assembly.”
BackgroundSelf-citationLi, M., Chen, X., Wang, H., Jurado, K. A., Engelman, A. N., & Craigie, R. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.040 · Cited by 18
Self-citationAromatic interaction profile to understand the molecular basis of raltegravir resistance
Balaraju, T., Kumar, A., Bal, C., Chattopadhyay, D., Jena, N., Bal, N. C., & Sharon, A. (2012) · Structural Chemistry · doi:10.1007/s11224-012-0181-1 · Cited by 18
“2b) the major binding phenomenon of RLT mediated by strong non-covalent interaction between diketo motif of RLT (red mesh) with conserved catalytic DDE motif (D64, D116, and E152: green mesh) using two metal ions (blue mesh) and its association with vDNA.”
BackgroundMethodResultInfluentialLi, M., Yang, R., Chen, X., Wang, H., Ghirlando, R., Dimitriadis, E. K., & Craigie, R. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168557 · Cited by 18
“Prototype foamy virus (PFV) and human T-cell lymphotropic virus type 1 (HTLV1) assemble tetramers 6,7 , Rous sarcoma virus (RSV) and mouse mammary tumor virus (MMTV) assemble octamers, 8,9 and maedi-visna virus (MMV) intasomes are hexadecameric.”
BackgroundMésplède, T., Quashie, P. K., Hassounah, S. A., Osman, N., Han, Y.-S., Liang, J., Singhroy, D. N., & Wainberg, M. A. (2015) · AIDS · doi:10.1097/qad.0000000000000752 · Cited by 20
“Molecular modeling was performed as previously described [20], using as a template the prototype foamy virus (PFV) integrase structure in either the target capture complex (PDB ID: 4E7K) [21] or in complex with EVG (PDB ID: 3L2U) [22].”
MethodSpecific features of HIV-1 integrase inhibition by bisphosphonate derivatives
Agapkina, J., Yanvarev, D. V., Anisenko, A. N., Korolev, S. P., Vepsäläinen, J., Kochetkov, S. N., & Gottikh, M. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.028 · Cited by 18
“In the case of INSTIs, a halogenated benzyl group was shown to be involved in stacking interactions with the cytosine of the conserved CA dinucleotide forcing the 30-OH of the terminal adenosine away from the IN active site [30,31].”
BackgroundImpact of Quaternary Structure Dynamics on Allosteric Drug Discovery
Jaffe, E. K. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313010006 · Cited by 19
“acts upon the DNA substrates; the second (outer dimer), in which the core domains interact, has no catalytic role [35].”
BackgroundThe successes and failures of HIV drug discovery
Hashimoto, C., Tanaka, T., Narumi, T., Nomura, W., & Tamamura, H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.611129 · Cited by 19
“The crystal structure of human foamy virus IN with viral DNA can be used as an alternative [91,92].”
Quashie, P. K., Han, Y.-S., Hassounah, S. A., Mésplède, T., & Wainberg, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128310 · Cited by 21
“All non-aligned residues were deleted to yield only a partially resolved outer monomer as observed in PFV IN dimeric and tetrameric structures [14, 19].”
BackgroundMethodResultShi, K., Pandey, K. K., Bera, S., Vora, A. C., Grandgenett, D. P., & Aihara, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056892 · Cited by 18
“Even though we do not have an experimentally determined RSV IN-DNA complex structure, the geometry in which the viral DNA terminus approaches the active site of RSV IN could be predicted based on the crystal structures of the PFV IN-DNA complex [7], as all retroviral INs catalyze essentially the same chemical reaction…”
BackgroundInfluentialAbrusán, G., & Marsh, J. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00220 · Cited by 19
Hage, K. E., Piquemal, J., Hobaika, Z., Maroun, R. G., & Gresh, N. (2014) · The Journal of Physical Chemistry A · doi:10.1021/jp5079899 · Cited by 19
Sgobba, M., Olubiyi, O. O., Song, K., & Haider, S. M. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.10507418 · Cited by 17
Miri, L., Bouvier, G., Kettani, A., Mikou, A., Wakrim, L., Nilges, M., & Malliavin, T. E. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24412 · Cited by 21
Métifiot, M., Johnson, B. C., Kiselev, E., Marler, L., Zhao, X. Z., Burke, T. R., Marchand, C., Hughes, S. H., & Pommier, Y. G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw592 · Cited by 16
“The binding of an INSTIs to the cleaved donor complex involves the displacement of the terminal nucleotide (−1 position, see Figure 1A for numbering convention) of the viral DNA from its normal binding in the IN active site (9).”
InfluentialTakahata, T., Takeda, E., Tobiume, M., Tokunaga, K., Yokoyama, M., Huang, Y.-L., Hasegawa, A., Shioda, T., Sato, H., Kannagi, M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02003-16 · Cited by 19
“foamy virus (33) and octamer forms for the Rous sarcoma virus (34) and mouse”
BackgroundMiller, J. T., Zhao, H., Masaoka, T., Varnado, B., Castro, E. M. C., Marshall, V. A., Kouhestani, K., Lynn, A. Y., Aron, K. E., Xia, A., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00233-18 · Cited by 16
Livani, Z. A., Safakish, M., Hajimahdi, Z., Soleymani, S., Zabihollahi, R., Aghasadeghi, M. R., Alipour, E., & Zarghi, A. (2018) · PubMed Central · Cited by 17
Barski, M. S., Vanzo, T., Zhao, X. Z., Smith, S. J., Ballandras-Colas, A., Cronin, N., Pye, V. E., Hughes, S. H., Burke, T. R., Cherepanov, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25284-1 · Cited by 20
“For the expression of LEDGF/ΔIBDB56γ, the previously described pET28a(+)SUMO-H6P-LEDGF/ΔIBDPPP2R5C(11-380) construct was used9.”
BackgroundSelf-citationRetroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 22
“The structure of the NED has been initially described in the context of nucleoprotein intasome assemblies formed by PFV IN [45,46].”
BackgroundInfluentialThe C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?
Rocchi, C., Gouet, P., Parissi, V., & Fiorini, F. (2022) · Viruses · doi:10.3390/v14071397 · Cited by 19
Wainberg, M. A. (2012) · Scientifica · doi:10.6064/2012/238278 · Cited by 18
“ese drugs contain a halogenated phenyl group that invades the catalytic pocket and displaces the 3 viral end [236, 240] and three coplanar oxygen atoms that chelate the divalent ions within the catalytic pocket, thus inhibiting the activity of the catalytic DDE triad [211, 213, 232, 241–243].”
BackgroundB-to-A transition in target DNA during retroviral integration
Jozwik, I. K., Li, W., Zhang, D., Wong, D., Grawenhoff, J., Ballandras-Colas, A., Aiyer, S., Cherepanov, P., Engelman, A., & Lyumkis, D. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac644 · Cited by 18
“Whereas SSCs/CSCs are obligate intermediates along the concerted integration pathway, quasi stable complexes promote h.s. integration (93,94).”
BackgroundInfluentialSelf-citationMajerz-Maniecka, K., Musioł, R., Skórska-Stania, A., Tabak, D., Mazur, P., Oleksyn, B. J., & Polański, J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.045 · Cited by 18
Impact of Resistance Mutations on Inhibitor Binding to HIV-1 Integrase
Chen, Q., Buolamwini, J. K., Smith, J. C., Li, A.-X., Xu, Q., Cheng, X., & Wei, D. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400537n · Cited by 22
Hage, K. E., Piquemal, J., Hobaika, Z., Maroun, R. G., & Gresh, N. (2014) · Journal of Computational Chemistry · doi:10.1002/jcc.23786 · Cited by 16
Gao, P., Cheng, X., Sun, L., Song, S. L., Álvarez, M., Luczkowiak, J., Pannecouque, C. C., Clercq, E. D., Menéndez‐Arias, L., Zhan, P., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.07.011 · Cited by 17
Araújo, A. R., Ribeiro, A. J. M., Fernandes, P. A., & Ramos, M. J. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct500570g · Cited by 16
A Versatile and Practical Synthesis toward the Development of Novel HIV‐1 Integrase Inhibitors
Rinaldi, M., Tintori, C., Franchi, L., Vignaroli, G., Innitzer, A., Massa, S., Esté, J. A., Gonzalo, E., Christ, F., Debyser, Z., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201000510 · Cited by 18
Structural Maturation of HIV-1 Reverse Transcriptase—A Metamorphic Solution to Genomic Instability
London, R. E. (2016) · Viruses · doi:10.3390/v8100260 · Cited by 16
“Active HIV protease (PR) is dimeric [14], and HIV integrase (IN) functions as a tetramer [15], similarly achieving n-fold reductions in coding, where in this case, n represents the number of”
BackgroundDecoding HIV Resistance: From Genotype to Therapy
Weber, I. T., & Harrison, R. W. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0048 · Cited by 16
“Instead, the structure of the foamy virus intasome has been used as a model for the HIV integrase complex with viral DNA [55] .”
MethodParizadeh, N., Alipour, E., Soleymani, S., Zabihollahi, R., Aghasadeghi, M. R., Hajimahdi, Z., & Zarghi, A. (2017) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426507.2017.1394302 · Cited by 16
Hajimahdi, Z., Zabihollahi, R., Aghasadeghi, M. R., & Zarghi, A. (2019) · Current HIV Research · doi:10.2174/1570162x17666190911125359 · Cited by 19
Foamy Virus Protein—Nucleic Acid Interactions during Particle Morphogenesis
Hamann, M. V., & Lindemann, D. (2016) · Viruses · doi:10.3390/v8090243 · Cited by 17
“Ultimately the p40IN subunit tetramerizes and associates with the linear, double-stranded viral DNA genome, generated by reverse transcription of the encapsidated PFV RNA genome, to form the intasome complex, which mediates proviral integration [84].”
BackgroundDevelopment of HIV-1 integrase inhibitors: recent molecular modeling perspectives
Su, M., Tan, J., & Lin, C. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.012 · Cited by 16
Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development
Masuda, T. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00210 · Cited by 22
“Recently, the entire prototype foamy virus (PFV) IN in a complex with its cognate vDNA ends, referred to as the intasome, has been successfully crystallized (Hare et al., 2010).”
BackgroundResultInfluentialFoamy virus assembly with emphasis on Pol encapsidation
Lee, E.-G., Stenbak, C., & Linial, M. (2013) · Viruses · doi:10.3390/v5030886 · Cited by 15
“The solution structure of the PFV IN tetramer has been solved [53,54].”
BackgroundInfluentialStructural modifications of quinolone-3-carboxylic acids with anti-HIV activity
He, Q., Gu, S., Liu, J., Wu, H.-Q., Zhang, X., Yang, L., Zheng, Y., & Chen, F. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.020 · Cited by 15
Foamy Retrovirus Integrase Contains a Pol Dimerization Domain Required for Protease Activation
Lee, E.-G., Roy, J., Jackson, D. L., Clark, P. K., Boyer, P. L., Hughes, S. H., & Linial, M. L. (2010) · Journal of Virology · doi:10.1128/jvi.01873-09 · Cited by 15
“Recent structural analysis shows that FV IN forms a dimer on each end of the viral DNA and that the dimers associate to form tetramers, bringing the two ends of the viral DNA together for integration (8).”
BackgroundCryo-EM structure of the Rous sarcoma virus octameric cleaved synaptic complex intasome
Pandey, K. K., Bera, S., Shi, K., Rau, M. J., Oleru, A. V., Fitzpatrick, J. A. J., Engelman, A. N., Aihara, H., & Grandgenett, D. P. (2021) · Communications Biology · doi:10.1038/s42003-021-01855-2 · Cited by 14
Self-citationDevelopment of LpxH Inhibitors Chelating the Active Site Dimanganese Metal Cluster of LpxH
Kwak, S., Cochrane, C. S., Cho, J. H., Dome, P. A., Ennis, A. F., Kim, J. H., Zhou, P., & Hong, J. (2023) · ChemMedChem · doi:10.1002/cmdc.202300023 · Cited by 14
Predicting protein–DNA interactions by full search computational docking
Roberts, V. A., Pique, M. E., Eyck, L. F. T., & Li, S. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24395 · Cited by 14
“The linker regions and the N-and C-terminal domains of PFV IN have little sequence similarity with HIV IN.70,71 To examine the structure of HIV IN in solution, we are currently applying the combined computational/DXMS approach used for UNG.”
MethodBurlein, C., Wang, C., Xu, M., Bhatt, T., Stahlhut, M. W., Ou, Y., Adam, G. C., Heath, J., Klein, D. J., Sanders, J. M., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00550 · Cited by 14
Safakish, M., Hajimahdi, Z., Aghasadeghi, M. R., Vahabpour, R., & Zarghi, A. (2019) · Current HIV Research · doi:10.2174/1570162x17666191210105809 · Cited by 19
Li, M., Lin, S., & Craigie, R. (2015) · Protein Science · doi:10.1002/pro.2837 · Cited by 16
Multifunctional facets of retrovirus integrase
Grandgenett, D. P., Pandey, K. K., Bera, S., & Aihara, H. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.83 · Cited by 23
Isaacs, D., Mikasi, S. G., Obasa, A. E., Ikomey, G. M., Shityakov, S., Cloete, R. E. A., & Jacobs, G. B. (2020) · Viruses · doi:10.3390/v12090936 · Cited by 14
Integrase: An Important Therapeutic Target in the Fight Against HIV/AIDS Infection
Santos, M. L. A., Albuquerque, M. G., & de Brito, M. A. (2014) · Revista Virtual de Química · doi:10.5935/1984-6835.20140058 · Cited by 25
Bulged DNA substrates for identifying poxvirus resolvase inhibitors
Culyba, M. J., Hwang, Y., Attar, S., Madrid, P. B., Bupp, J. E., Huryn, D. M., Sanchez, L., Grobler, J. A., Miller, M. D., & Bushman, F. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks325 · Cited by 14
“These inhibitors contain a metal chelating pharmacophore that is thought to disrupt catalysis by binding divalent metal-ion cofactors at the enzyme active site (12,13).”
Insight into the ERVK Integrase – Propensity for DNA Damage
Bray, S., Turnbull, M., Hebert, S., & Douville, R. N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01941 · Cited by 14
“Blue annotations reflect additional amino acids conserved within retroviral IN proteins. conserved aspartic acid (D) residues and a glutamic acid (E) residue that form a catalytic triad called the DDE motif (Hare et al., 2010).”
BackgroundSingh, P., Li, W., Bedwell, G., Fadel, H., Poeschla, E., & Engelman, A. (2022) · Viruses · doi:10.3390/v14091883 · Cited by 13
Self-citationTautomerism and Magnesium Chelation of HIV‐1 Integrase Inhibitors: A Theoretical Study
Liao, C., & Nicklaus, M. C. (2010) · ChemMedChem · doi:10.1002/cmdc.201000039 · Cited by 13
Anisenko, A. N., Agapkina, J., Zatsepin, T. S., Yanvarev, D. V., & Gottikh, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.009 · Cited by 13
“The exact structure of the HIV-1 IN complex with DNA has not been known yet, but it was simulated based on the X-ray structure of the PFV intasome [24,25].”
MethodResultGhitti, M., Musco, G., & Spitaleri, A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-02970-2_12 · Cited by 15
“In this context MD simulations were able to successfully predict more than one possible orientation of HIV ligands binding [108, 109], as later confirmed by crystallography studies [110, 111].”
MethodSchreier, J. D., Embrey, M. W., Raheem, I. T., Barbe, G., Campeau, L., Dubost, D. C., Dunn, J. M. M., Grobler, J. A., Hartingh, T. J., Hazuda, D. J., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.039 · Cited by 13
Two new tetracyclic triterpenoids from the endophytic fungus Hypoxylon sp. 6269
Liang, H., Zhang, D., Guo, S., & Yu, J. (2018) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2018.1485662 · Cited by 13
Demange, A., Yajjou, H., Gallay, K., Luengo, C., Béven, V., Leroux, A., Confort, M.-P., Andary, E. A., Gouet, P., Moreau, K., et al. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000236 · Cited by 15
“…IN is closely related to MLV IN, sharing 50 % sequence identity in total, with 22 % for the NTD, 72 % for the CCD and 50 % for the CTD. PERV-A/C IN also shares a significant 26 % sequence identity with PFV IN, whose full-length structure is known (Hare et al., 2010a; Maertens et al., 2010).”
BackgroundMethodWright, D. W., Wan, S., Shublaq, N. W., Zasada, S. J., & Coveney, P. V. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1186 · Cited by 14
“More recently a crystal structure of the full proto foamy virus IN tetramer has been produced 34 which has led to a homology model of the full HIV IN. 35 With these models in place the first steps are being made to investigate the binding properties of raltegravir and other IN inhibitors in detail.”
MethodVirus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Self-citationLi, M., Li, Z., Chen, X., Cui, Y., Engelman, A. N., & Craigie, R. (2024) · Viruses · doi:10.3390/v16071166 · Cited by 12
“Whereas foamy viruses use the minimal number of 4 subunits to construct a tetrameric IN intasome [4], β -retroviruses and Maedi-visna virus, a sheep lentivirus, use 8 and 16 subunits, respectively [5,6].”
BackgroundSelf-citationModeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors
Yin, Z., & Craigie, R. (2010) · Viruses · doi:10.3390/v2122777 · Cited by 13
“Although it is well over a decade since the structures of all three domains of HIV-1 integrase were determined [4–7], the first structure of a retroviral intasome—that of prototype foamy virus (PFV)—has only recently been solved [8].”
BackgroundBallandras-Colas, A., Moreau, K., Robert, X., Confort, M.-P., Merceron, R., Haser, R., Ronfort, C., & Gouet, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023032 · Cited by 16
“Such face-to-face interface between canonical dimers is not observed in the structure of the PFV intasome [16].”
BackgroundProkaryotic Argonaute from Archaeoglobus fulgidus interacts with DNA as a homodimer
Golovinas, E., Rutkauskas, D., Manakova, E., Jankunec, M., Šilanskas, A., Sasnauskas, G., & Zaremba, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83889-4 · Cited by 11
“Instead, the ability of WT AfAgo to form stable synaptic complexes with two DNA ends is reminiscent of transposases [40–43], Cas1-Cas2 integrases [47,48], and (retro)viral integrases [49,50], which often bring the reactive 3′-OH groups of two DNA ends into proximity of the integration site.”
BackgroundStructural Basis of Mos1 Transposase Inhibition by the Anti-retroviral Drug Raltegravir
Wolkowicz, U. M., Morris, E. R., Robson, M. I., Trubitsyna, M., & Richardson, J. M. (2014) · ACS Chemical Biology · doi:10.1021/cb400791u · Cited by 13
Dolutegravir: an exciting new kid on the block
Blanco, J. L., & Whitlock, G. G. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.868883 · Cited by 14
“RAL, EVG and DTG displace viral DNA in the active site and contact several active-site amino acids -- including those in a mobile loop extending between positions 140 -- 149 [4-6].”
MethodInfluentialChen, Q., Wei, D., Xu, Q., & Cheng, X. (2014) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-014-0235-8 · Cited by 12
“In 2010, the crystal structure of the full length PFV in complex with virus DNA and inhibitor Elvitegravir was reported [2].”
BackgroundDesign and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors
Yu, S., Sanchez, T. W., Liu, Y., Yin, Y., Neamati, N., & Zhao, G. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.018 · Cited by 12
N-terminal half of transportin SR2 interacts with HIV integrase
Tsirkone, V. G., Blokken, J., Wit, F. D., Breemans, J., Houwer, S. D., Debyser, Z., Christ, F., & Strelkov, S. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777029 · Cited by 16
“A crystal structure of the prototype foamy virus intasome has revealed a tetramer of IN bound to DNA, which is the minimal functional state required for a concerted integration (57).”
BackgroundFRET analysis of HIV‐1 Gag and GagPol interactions
Takagi, S., Momose, F., & Morikawa, Y. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12328 · Cited by 12
Structure-Driven Discovery of α,γ-Diketoacid Inhibitors Against UL89 Herpesvirus Terminase
Bongarzone, S., Nadal, M., Kaczmarska, Z., Machón, C., Álvarez, M., Alberício, F., & Coll, M. (2018) · ACS Omega · doi:10.1021/acsomega.8b01472 · Cited by 12
Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition
Vanangamudi, M., Nair, P. C., Maida Engels, S. E., Senthilkumar, P., & Namasivayam, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_3 · Cited by 13
Mechanisms of DNA Transposition
Hickman, A. B., & Dyda, F. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch25 · Cited by 15
Local features determine Ty3 targeting frequency at RNA polymerase III transcription start sites
Patterson, K., Shavarebi, F., Magnan, C., Chang, I., Qi, X., Baldi, P., Bilanchone, V., & Sandmeyer, S. B. (2019) · Genome Research · doi:10.1101/gr.240861.118 · Cited by 16
“…after repair of the two gaps, the characteristic TSD. Recent structural analysis of the retroviral intasome has highlighted a structural role for a flexible YR (pyrimidine/purine) dinucleotide in enabling IN active site target access (Hare et al. 2010; Maertens et al. 2010; Serrao et al. 2014).”
BackgroundThe Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario
Renzi, G., Carta, F., & Supuran, C. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512187 · Cited by 12
Cutillas, V., Mésplède, T., Anstett, K., Hassounah, S. A., & Wainberg, M. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04274-14 · Cited by 12
“template to generate a WT subtype B dimeric model (20, 21).”
MethodMackler, R. M., Jones, N. D., Gardner, A. M., Lopez, M. A., Howard, C. J., Fishel, R. A., & Yoder, K. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212764 · Cited by 10
Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses
Lee, G.-E., Mauro, E., Parissi, V., Shin, C., & Lesbats, P. (2019) · Viruses · doi:10.3390/v11090770 · Cited by 11
“Determined by X-ray crystallography, the structure of the PFV intasome fundamentally changed the landscape in the field of retroviral integration, as it could both unravel the functional architecture of the integration apparatus and elucidate the mechanism of action of HIV strand transfer inhibitors [9].”
BackgroundInfluentialInhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles
Sanna, V., Youssef, M. F., Pala, N., Rogolino, D., Carcelli, M., Singh, P. K., Sanchez, T. W., Neamati, N., & Sechi, M. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00648 · Cited by 12
Metadata
- Authors
- Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Cherepanov, Peter
- Venue
- Nature
- Published
- 2010-01-31
- Volume
- 464
- Issue
- 7286
- Pages
- 232-236
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2837123
- OpenAlex
- W2025344323
- Cited by
- 678
- References
- 50
- Citations by year
- 2026: 14 · 2025: 10 · 2024: 15 · 2023: 21 · 2022: 19 · 2021: 31 · 2020: 29 · 2019: 38 · 2018: 33 · 2017: 31 · 2016: 43 · 2015: 53 · 2014: 49 · 2013: 68 · 2012: 79
- FWCI
- 60.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Diamond Light Source
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (R01AI070042, P30AI060354)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retroviral integrase, intasome, DNA strand transfer, HIV-1 integrase, integrase strand transfer inhibitors, raltegravir, elvitegravir, antiretroviral drug development, viral DNA integration, protein-DNA interactions
- MeSH terms
- DNA, Viral, Models, Molecular, Retroviridae, HIV-1, Protein Structure, Tertiary, Integrases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.